Skip to content
AlternativeMed

ADAPTOGENS · GUIDE

Research by Ingredient

A side-by-side evidence table for ashwagandha, ginseng, rhodiola, eleuthero, schisandra, holy basil, maca, astragalus and licorice, with plant part, strength of evidence and key cautions.

Content last updated . This page has not been medically reviewed.

Back to Adaptogen Research & Evidence

Safety first. Natural products can cause side effects and interact with medicines. Read who should be careful, by situation before you use anything on this page.

Information only. This table summarizes what the sources we read say. It does not say that any herb treats a condition, and it is not a ranking. A finding applies only to the plant, part, extract, population and outcome in the study. Ask a pharmacist or clinician before using any of these, and see how medicine interactions work.

How to use this page

Use it to see, at a glance, how much and what kind of human research the sources describe for each ingredient. Open the ingredient's own guide for details. The labels used are the library's standard ones: promising but limited, mixed, insufficient evidence, traditional use only, preclinical (cells or animals). "Proper evidence not found" means we searched and did not find usable evidence in the sources named.

PubMed record counts

The counts below show how many records exist in PubMed, a research database. A count shows volume of publication, not whether an ingredient works or how good the studies are.
IngredientRecords tagged as randomized controlled trialsRecords tagged as any clinical trialAll PubMed records that mention itCheck it yourself
Ashwagandha61792,258PubMed search
Rhodiola60691,482PubMed search
Asian ginseng1291545,176PubMed search
American ginseng4348936PubMed search
Eleuthero2430541PubMed search
Holy basil (tulsi)17211,073PubMed search
Schisandra14191,678PubMed search
Amla29361,200PubMed search
Astragalus911165,314PubMed search
Shatavari913300PubMed search
Maca1415703PubMed search
Licorice root1221736,381PubMed search

Counted 2026-10-22 using NCBI E-utilities. Counts include studies of extracts, blends and non-health topics, and a trial can find no effect. A higher count means more human research has been indexed, not that something works.

Evidence table

Scientific names were checked against the GBIF taxonomy. [1]
Ingredient (plant part)What the source foundEvidence labelPopulation and form studied
Ashwagandha (Withania somnifera; root, leaf or root/leaf extract) [2]NCCIH: some preparations may be effective for insomnia and stress; unclear for anxiety; not enough evidence for conditions such as athletic performance or cognitive function. [2] A 2022 meta-analysis of 12 trials reported lower anxiety and stress, with low certainty of evidence and large variation between trials. [3] A 2026 meta-analysis of 22 trials called for high-quality trials. [4]Promising but limited (stress, sleep); mixed (anxiety)Adults, mostly aged 25 to 48 in the 2022 pool; many preparations [3]
Asian ginseng (Panax ginseng; root) [5]NCCIH: a possible small benefit for general fatigue, but not all research agrees; most research shows no athletic benefit. [5]MixedMostly trials under 200 people and under 3 months [5]
American ginseng (Panax quinquefolius)A 2018 review covered both Asian and American ginseng for fatigue in people with chronic illness and found modest evidence and a low risk of adverse events. [6] Proper evidence not found for an American-ginseng-only review in the sources we read (we searched NCCIH and PubMed).Promising but limited, species not separatedPeople with fatigue linked to chronic illness; 10 studies [6]
Eleuthero (Eleutherococcus senticosus; root; older name Acanthopanax senticosus) [1][7]A 2008 European committee paper found none of the studies sufficient to substantiate efficacy in a clearly defined condition. [8] Proper evidence not found for a newer systematic review in the sources we read.Insufficient evidenceMixed small studies reviewed in 2008 [8]
Rhodiola (Rhodiola rosea; root and rhizome) [9]NCCIH: not enough reliable evidence for any purpose; research mostly low to moderate quality. [10] A 2011 review found 11 randomized trials, mostly moderate or good quality, but lacking independent replication. [11] A 2012 review rated all studies as high risk of bias or having reporting flaws and called the research contradictory. [12]Insufficient evidence; reviews disagreeHealthy adults and some patient groups; extract varied
Schisandra (Schisandra chinensis; fruit) [13]One small randomized trial in women with menopausal symptoms enrolled 41 people and 36 completed it, with treatment for 6 weeks and follow-up to 12 weeks. [14] A review of Russian research reports numerous clinical trials in asthenia and other conditions, but its abstract does not appraise their quality. [15] Proper evidence not found for a systematic review of human trials in the sources we read.Insufficient evidence; Soviet-era trials not independently appraised hereWomen 40 to 70 in the one trial [14]
Holy basil / tulsi (Ocimum tenuiflorum, formerly Ocimum sanctum) [1]A 2017 review identified 24 studies and reported favourable outcomes with no significant adverse events, but its search included books, theses and conference proceedings and its authors said more studies are needed. [16]Promising but limitedVaried; plant part and form varied across studies
Maca (Lepidium meyenii) [1]A 2011 systematic review of menopausal symptoms included four randomized trials and found limited evidence, with safety not proven. [17]Promising but limitedPerimenopausal and postmenopausal women [17]
Astragalus (Astragalus membranaceus; root) [18]NCCIH: not sufficient reliable evidence for any health condition; reviews it cites found small studies of mostly low quality. [18]Insufficient evidenceVaries by condition
Licorice (Glycyrrhiza glabra and relatives; root) [19]NCCIH: not enough high-quality evidence for any health condition. [19]Insufficient evidenceMostly mouth rinses, gargles and topical forms [19]

Other plants in this library. For amla, codonopsis, jiaogulan, guduchi, rhaponticum, cistanche, he shou wu, notoginseng, tongkat ali and pine pollen, this page does not summarize human evidence. Check each herb's own guide; where no usable evidence was read, the guide says so.

What this table cannot tell you

  • A review of "ginseng" may mix Asian and American ginseng, and eleuthero is a different plant, so do not move results between them. [6][1]
  • Counts of studies do not tell you quality. Compare human clinical studies for limits and conflicts of interest.
  • NCCIH pages are updated over time; this table reflects pages read on 2026-10-23.
  • For the big picture, return to adaptogen research and evidence.

Frequently asked questions

Which adaptogen has the most evidence?

We do not rank them. The reviews we found cover ashwagandha, ginseng and rhodiola most, but with limits: low certainty for ashwagandha, mixed for ginseng, and conflicting quality judgments for rhodiola. [3][5][11][12]

Is there good evidence for schisandra?

We found one small randomized trial and a review of Russian research whose abstract reports many clinical trials without appraising them. [14][15] That is insufficient evidence from the sources we read, not evidence that it does not work.

Why do reviews of the same herb disagree?

They can ask different questions and judge quality differently. Two rhodiola reviews, for example, reached different judgments about the same kind of trials. [11][12]

Does a record count in PubMed show an ingredient works?

No. It shows how many records exist, not whether the ingredient is effective or the studies are good.

Where can I read about one ingredient in depth?

Start with the guides for ashwagandha, rhodiola, Asian ginseng or the A to Z directory.

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

Cautions that come with the evidence
This is not a full safety list. See adaptogen safety essentials and each ingredient's guide.
  • Ashwagandha: rare liver injury cases, avoid in pregnancy and while breastfeeding, not recommended before surgery or with autoimmune or thyroid disorders, and possible interactions with diabetes, blood pressure, immune, sedative, seizure and thyroid medicines. [2]
  • Asian ginseng: insomnia is the most common side effect; it may interfere with blood clotting, may worsen autoimmune disorders, and might lower blood sugar. Some experts recommend against use for infants, children, and pregnant or breastfeeding women. [5]
  • Rhodiola: interactions with losartan have been reported, and little is known about pregnancy or breastfeeding. [10]
  • Astragalus: might worsen autoimmune disease symptoms. [18]
  • Licorice: the component glycyrrhizin can cause serious adverse effects such as irregular heartbeat. [19]
  • Any of them with antidepressants: a 2023 chart review of adverse event reports advised clinicians to monitor. [20]

Tell your surgical team about every supplement, and ask the prescriber or pharmacist before combining any with a medicine. Do not start, stop or change a prescribed medicine on the basis of this page. Product quality varies, so see quality testing and certifications.

References
  1. GBIF Secretariat. GBIF Backbone Taxonomy, species match service, queried for each plant name used on this page. Read 2026-10-23.
  2. National Center for Complementary and Integrative Health (NIH). Ashwagandha: Usefulness and Safety. Read 2026-10-23.
  3. Phytother Res 2022. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Abstract read 2026-10-23.
  4. Complement Ther Med 2026. Effects of ashwagandha (Withania somnifera) on mental health in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Abstract read 2026-10-23.
  5. National Center for Complementary and Integrative Health (NIH). Asian Ginseng: Usefulness and Safety. Read 2026-10-23.
  6. J Altern Complement Med 2018. Ginseng as a Treatment for Fatigue: A Systematic Review. Systematic review, abstract read 2026-10-23.
  7. Nutrients 2026. System-Level, Molecular and Cellular Mechanisms of Selected Plant Adaptogens - A Review. Review, full text read 2026-10-23.
  8. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Reflection paper on the adaptogenic concept (EMEA/HMPC/102655/2007), adopted 8 May 2008. Read 2026-10-23.
  9. Phytomedicine 2010. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Review, abstract read 2026-10-23.
  10. National Center for Complementary and Integrative Health (NIH). Rhodiola: Usefulness and Safety. Read 2026-10-23.
  11. Phytomedicine 2011. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Systematic review, abstract read 2026-10-23.
  12. BMC Complement Altern Med 2012. Rhodiola rosea for physical and mental fatigue: a systematic review. Systematic review, abstract read 2026-10-23.
  13. Nutrients 2021. Plant Adaptogens - History and Future Perspectives. Review, full text read 2026-10-23.
  14. Climacteric 2016. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Trial, abstract read 2026-10-23.
  15. J Ethnopharmacol 2008. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. Review, abstract read 2026-10-23.
  16. Evid Based Complement Alternat Med 2017. The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature. Abstract read 2026-10-23.
  17. Maturitas 2011. Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review. Abstract read 2026-10-23.
  18. National Center for Complementary and Integrative Health (NIH). Astragalus: Usefulness and Safety. Read 2026-10-23.
  19. National Center for Complementary and Integrative Health (NIH). Licorice Root: Usefulness and Safety. Read 2026-10-23.
  20. Front Pharmacol 2023. Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs. Abstract read 2026-10-23.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.